Response Biomedical Corp. (RPBIF.OB) Announces Preliminary Year-End 2009 Results
Response Biomedical Corp., a leading developer, manufacturer and marketer of rapid on-site diagnostic tests, recently announced the company’s preliminary year-end 2009 financial results. The company expects to report annual revenues of roughly $10 million for 2009, compared to $5.87 million in 2008. On March 25, 2009, the company will host a conference call and announce complete fourth quarter and year-end financial results. Response Biomedical’s proprietary technology is the RAMP® Platform that is utilized for clinical and environmental applications. The company’s RAMP® system consists of a reader and single-use disposable test cartridges that can be adapted to over 250 medical and…